Characteristic, mean ± SD unless specified otherwise | All (N = 3336) | Female (n = 1486) 45% | Male Female (n = 1850) 55% | P-value |
---|---|---|---|---|
Demographic | ||||
Gulf citizen, n (%) | 2667 (80%) | 1337 (90%) | 1330 (72%) | < 0.001 |
Age, years | 57 ± 11 | 57 ± 10 | 57 ± 11 | 0.883 |
Weight, kg | 83 ± 18 | 80 ± 17 | 85 ± 18 | < 0.001 |
Waist circumference, cm | 105 ± 14 | 104 ± 14 | 105 ± 14 | 0.097 |
BMI, kg/m2 | 32 ± 7 | 34 ± 7 | 30 ± 6 | < 0.001 |
BMI > 30 kg/m2, n (%) | 1843 (55%) | 1018 (69%) | 825 (45%) | < 0.001 |
Clinical, n (%) | ||||
Current smoker | 381 (11%) | 21 (1.4%) | 360 (19%) | < 0.001 |
Hypertension | 2330 (70%) | 1031 (69%) | 1299 (70%) | 0.601 |
Coronary heart disease | 999 (30%) | 251 (17%) | 748 (40%) | < 0.001 |
PVD | 101 (3.0%) | 35 (2.4%) | 66 (3.6%) | 0.042 |
Cerebrovascular disease | 135 (4.1%) | 44 (3.0%) | 91 (4.9%) | 0.004 |
Metabolic syndrome | 2437 (76%) | 1172 (81%) | 1265 (72%) | < 0.001 |
Very high ACSVD risk | 2755 (83%) | 1110 (75%) | 1645 (89%) | < 0.001 |
HbA1c, % | 8.6% ± 3.7% | 8.7% ± 3.5% | 8.5% ± 3.9% | 0.001 |
HbA1c < 7% | 863 (26%) | 382 (26%) | 481 (26%) | 0.851 |
Dyslipidemia therapy, n (%) | ||||
Statin monotherapy | 3160 (95%) | 1439 (97%) | 1721 (93%) | < 0.001 |
Statin combination | 145 (4.4%) | 41 (2.8%) | 104 (5.6%) | < 0.001 |
Othersa | 31 (0.9%) | 6 (0.4%) | 25 (1.4%) | 0.005 |
Lipid levels on treatment | ||||
TC | 4.28 ± 1.09 | 4.47 ± 1.08 | 4.13 ± 1.08 | < 0.001 |
LDL-C | 2.50 ± 0.90 | 2.59 ± 0.89 | 2.42 ± 0.90 | < 0.001 |
HDL-C | 1.16 ± 0.31 | 1.28 ± 0.31 | 1.06 ± 0.27 | < 0.001 |
ApoB, g/L | 0.91 ± 0.27 | 0.93 ± 0.27 | 0.89 ± 0.27 | < 0.001 |
Non-HDL-C | 3.13 ± 1.06 | 3.19 ± 1.08 | 3.07 ± 1.05 | 0.001 |
TG | 1.79 ± 1.37 | 1.73 ± 1.30 | 1.84 ± 1.42 | 0.021 |